Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 10 Years - IDEXX Laboratories ( NASDAQ:IDXX )
IDEXX Laboratories ( NASDAQ:IDXX ) has outperformed the market over the past 10 years by 14.09% on an annualized basis producing an average annual return of 26.23%. Currently, IDEXX Laboratories has a market capitalization of $58.83 billion.
3 Reasons Why Growth Investors Shouldn't Overlook Idexx ( IDXX )
Idexx (IDXX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Idexx Laboratories ( IDXX ) Recently Broke Out Above the 20-Day Moving Average
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
Molina Secures Deal From AHCA to Serve Florida's Medicaid Members
MOH wins sole contract from AHCA to manage care for around 120,000 Florida enrollees of SMMC and CHIP through a Medicaid deal.
TFX Stock Falls Despite Q3 Earnings and Revenue Beat, '25 View Down
Teleflex posts strong Q3 earnings and revenue beats but trims 2025 outlook, sending shares slightly lower.
ALC's Q3 Earnings Beat, Revenues Miss, Stock Rises in After-Market Hours
Alcon posts mixed Q3 results as earnings top estimates but revenues miss. new product launches fuel optimism.
VCYT Stock Gains on Q3 Earnings and Revenue Beat, '25 View Up
Veracyte surges 27.5% after Q3 earnings and revenues beat estimates, driven by strong Decipher and Afirma test growth.
Peering Into IDEXX Laboratories Inc's Recent Short Interest - IDEXX Laboratories ( NASDAQ:IDXX )
IDEXX Laboratories Inc's ( NYSE:IDXX ) short interest as a percent of float has fallen 4.35% since its last report. According to exchange reported data, there are now 1.78 million shares sold short, which is 2.86% of all regular shares that are available for trading.
STE Stock Gains on Q2 Earnings and Revenue Beat, '26 EPS View Up
STERIS posts strong Q2 results with earnings and revenue beats, margin expansion, and a raised 2026 EPS outlook.
Zimmer Biomet Q3 Earnings Top but Revenue Miss Causes Pre-Market Drop
Zimmer Biomet's Q3 EPS beats expectations, but a revenue miss and trimmed outlook send shares sliding in pre-market trading.
TEM's Q3 Earnings & Revenues Beat, Stock Down in After-Market Hours
Tempus AI reports a narrower-than-expected Q3 loss and stronger revenues, raises full-year outlook, but shares decline following the results.
TECH Stock Falls on Q1 Earnings Meet, Revenues Miss, Margins Up
Bio-Techne's Q1 earnings meet expectations, but revenues slip 1%, sending shares lower despite stronger margins.
3 Reasons Why Growth Investors Shouldn't Overlook Idexx ( IDXX )
Idexx (IDXX) possesses solid growth attributes, which could help it handily outperform the market.
Company News for Nov 4, 2025
Companies in The News Are: ...
Idexx Laboratories ( IDXX ) Just Flashed Golden Cross Signal: Do You Buy?
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
Idexx Laboratories ( IDXX ) Just Overtook the 50-Day Moving Average
When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?
HSIC Stock Jumps on Q3 Earnings and Revenue Beat, '25 Outlook Up
Henry Schein's Q3 earnings and revenues top estimates, lifting the stock as the company raised its 2025 outlook on solid business momentum.
Meta Platforms, S&P Global And A Health Care Stock: CNBC's 'Final Trades' - Meta Platforms ( NASDAQ:META ) , IDEXX Laboratories ( NASDAQ:IDXX )
On CNBC's "Halftime Report Final Trades," Stephen Weiss, chief investment officer and managing partner of Short Hills Capital Partners, recommended buying Meta Platforms, Inc. ( NASDAQ:META ) , which is down almost 20% from its high. Meta, on Wednesday, Oct. 29, posted upbeat third-quarter ...
Why Idexx Laboratories Stock Surged by Almost 15% Today
Investors were barking for some shares thanks to a better-than-expected earnings report.
Idexx Laboratories Extends Rally Following Upbeat Q3 Earnings - IDEXX Laboratories ( NASDAQ:IDXX )
IDEXX Laboratories Inc.'s ( NASDAQ:IDXX ) stock is trading higher on Monday after it reported better-than-expected third-quarter financial results and raised its 2025 forecast. The animal health company reported third-quarter 2025 adjusted earnings of $3.22 per share, up 15% year over year, ...
IDEXX ( IDXX ) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Monday, Nov. 3, 2025 at 8:30 a.m. ETPresident and Chief Executive Officer - Jay MazelskyContinue reading ...
IDEXX Laboratories Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - IDEXX Laboratories ( NASDAQ:IDXX )
IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) will release earnings results for the third quarter, before the opening bell on Monday, Nov. 3. Analysts expect the Westbrook, Maine-based company to report quarterly earnings at $3.14 per share, up from $2.80 per share in the year-ago period.
ON Semiconductor, Williams Companies And 3 Stocks To Watch Heading Into Monday - ON Semiconductor ( NASDAQ:ON )
With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Williams Companies Inc ( NYSE:WMB ) to report quarterly earnings at 51 cents per share on revenue of $2.89 billion after the closing bell, ...
If You Invested $100 In IDEXX Laboratories Stock 10 Years Ago, You Would Have This Much Today - IDEXX Laboratories ( NASDAQ:IDXX )
IDEXX Laboratories ( NASDAQ:IDXX ) has outperformed the market over the past 10 years by 12.0% on an annualized basis producing an average annual return of 24.51%. Currently, IDEXX Laboratories has a market capitalization of $51.31 billion.
Apple To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Friday - Apple ( NASDAQ:AAPL ) , Amazon.com ( NASDAQ:AMZN )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Stifel raised Amazon.com, Inc. ( NASDAQ:AMZN ) price target from $269 to $295.
This Hershey Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday - IDEXX Laboratories ( NASDAQ:IDXX ) , Hershey ( NYSE:HSY )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Countdown to Idexx ( IDXX ) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Besides Wall Street's top-and-bottom-line estimates for Idexx (IDXX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.
ECL Stock Falls in Pre-Market Despite Q3 Earnings Beat, Margins Expand
Ecolab tops third-quarter 2025 estimates with strong margin gains and lifts full-year EPS outlook amid steady segment growth.
Earnings Preview: PROCEPT BioRobotics Corporation ( PRCT ) Q3 Earnings Expected to Decline
PROCEPT BioRobotics (PRCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Idexx Laboratories ( IDXX ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Bio-Techne Q1 Earnings Preview: What's in Store for the Stock?
TECH's Q1 results could reflect steady Protein Sciences growth but pressure in Spatial Biology amid NIH and biotech funding uncertainty.
BFLY Q3 Earnings Preview: Strategic Progress Likely to Support Growth
Butterfly Network's Q3 earnings may have been shaped by iQ3 adoption, software growth and strategic progress.
STERIS to Report Q2 Earnings: Here's What to Expect
STE is set to post fiscal Q2 results on Nov. 6, with estimates pointing to solid revenue and earnings growth across key segments.
HOLX or IDXX: Which Is the Better Value Stock Right Now?
HOLX vs. IDXX: Which Stock Is the Better Value Option?
Zimmer Biomet to Report Q3 Earnings: Here's What to Expect
ZBH's Q3 results on Nov. 5 may show solid gains, driven by hip, knee, and S.E.T. segment growth and recent product approvals.
Is First Trust NASDAQ-100 Ex-Technology Sector ETF ( QQXT ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Manitou Investment Management Offloads $12 Million of Home Depot ( NYSE: HD ) Shares: What Should Investors Do?
On October 17, 2025, Manitou Investment Management Ltd. disclosed in a Securities and Exchange Commission filing for the period ended Q3 2025 that it sold 30,004 shares of The Home Depot. This was an estimated $11.80 million trade based on the average price for the quarter.According to a filing ...
ALGN Gears Up for Q3 Earnings: What Lies Ahead for the Stock?
Align Technology readies its Q3 report, with steady Clear Aligner demand and scanner upgrades expected to shape its performance.
Here's How IDEXX Laboratories is Placed Ahead of Q3 Earnings
IDXX heads into Q3 earnings with steady estimates and strong momentum across its diagnostics and pet healthcare segments.
Robust TAVR Growth to Drive Edwards Lifesciences' Q3 Earnings
Strong TAVR demand and expanding valve therapies are set to power EW's Q3 results despite lower EPS estimates.
If You Invested $100 In IDEXX Laboratories Stock 10 Years Ago, You Would Have This Much Today - IDEXX Laboratories ( NASDAQ:IDXX )
IDEXX Laboratories ( NASDAQ:IDXX ) has outperformed the market over the past 10 years by 11.38% on an annualized basis producing an average annual return of 24.03%. Currently, IDEXX Laboratories has a market capitalization of $51.82 billion.
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
TMO to Report Q3 Earnings: Life Science Solutions Segment in Focus
Thermo Fisher's Q3 results on Oct. 22 are set to spotlight gains from new launches and acquisitions across key growth segments.
Will Robust Cardiovascular Performance Fuel BSX's Q3 Earnings?
Boston Scientific's strong cardiovascular and MedSurg momentum, powered by innovations like WATCHMAN FLX Pro and AGENT DCB, could drive solid Q3 results.
Labcorp Gears Up to Report Q3 Earnings: What's in Store for the Stock?
LH is poised for Q3 growth, with revenue and EPS estimates pointing higher as diagnostics and biopharma units deliver strong performances.
Is Invesco S&P 500 Equal Weight Health Care ETF ( RSPH ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Seilern Investment Management Sells $43 Million Worth of IDEXX Laboratories ( NASDAQ: IDXX ) Stock
Seilern Investment Management Ltd disclosed the sale of 70,900 shares of IDEXX Laboratories for the period ended September 30, 2025, an estimated $43.03 million trade based on the average price for Q3 2025, per its October 14, 2025, SEC filing.According to a filing with the U.S.
Here's How Quest Diagnostics Is Placed Ahead of Q3 Earnings
DGX is poised for solid Q3 2025 results, backed by strong DIS growth, strategic M&A and robust test demand across key health segments.
Why Idexx ( IDXX ) is Poised to Beat Earnings Estimates Again
Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
